Compare SCL & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SCL | RAPP |
|---|---|---|
| Founded | 1932 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 1994 | 2024 |
| Metric | SCL | RAPP |
|---|---|---|
| Price | $49.44 | $27.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $75.00 | $47.00 |
| AVG Volume (30 Days) | 160.3K | ★ 248.7K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.13% | N/A |
| EPS Growth | N/A | ★ 83.64 |
| EPS | ★ 2.05 | N/A |
| Revenue | ★ $1,803,737,000.00 | N/A |
| Revenue This Year | $6.98 | N/A |
| Revenue Next Year | $4.69 | N/A |
| P/E Ratio | $24.66 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $41.82 | $7.42 |
| 52 Week High | $68.00 | $42.27 |
| Indicator | SCL | RAPP |
|---|---|---|
| Relative Strength Index (RSI) | 30.66 | 47.68 |
| Support Level | $47.21 | $25.22 |
| Resistance Level | $51.10 | $29.84 |
| Average True Range (ATR) | 2.52 | 2.21 |
| MACD | -2.10 | -0.04 |
| Stochastic Oscillator | 6.09 | 32.81 |
Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.